Transthyretin as both a sensor and a scavenger of β-amyloid oligomers

Biochemistry

Volumn 52, Issue 17, 2013, Pages 2849-2861

  Yang, Dennis T ^a   Joshi, Gururaj ^b   Cho, Patricia Y ^a   Johnson, Jeffrey A ^b   Murphy, Regina M ^a  

^a University of Wisconsin Madison   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROPHOBIC POCKETS; MECHANISM OF ACTION; NANOPARTICLE TRACKING; NOVEL TECHNIQUES; TETRAMER STABILITY; TETRAMERIC STRUCTURES; TRANSPORT FUNCTION; TRANSPORT PROTEINS;

CELL DEATH; GLYCOPROTEINS; HYDROPHOBICITY; MONOMERS; OLIGOMERS; PROTEINS; TOXIC MATERIALS;

AGGREGATES;

AMYLOID BETA PROTEIN; PREALBUMIN; SCAVENGER; TETRAMER;

ALPHA HELIX; ANIMAL CELL; ARTICLE; CELL AGGREGATION; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; GENETIC STABILITY; GROWTH INHIBITION; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; MOLECULAR SENSOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN PURIFICATION; WILD TYPE;

AMYLOID BETA-PEPTIDES; BINDING SITES; BIOPOLYMERS; BLOTTING, WESTERN; CIRCULAR DICHROISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; KINETICS; MODELS, MOLECULAR; NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS; PREALBUMIN; PROTEIN BINDING;

EID: 84877049480     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi4001613     Document Type: Article

References (42)

1. Johnson, J. A. and Stein, T. D. (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways J. Neurosci. 22, 7380-7388
2. Johnson, J. A., Stein, T. D., Anders, N. J., DeCarli, C., Chan, S. L., and Mattson, M. P. (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APP(Sw) mice resulting in tau phosphorylation and loss of hippocampal neurons: Support for the amyloid hypothesis J. Neurosci. 24, 7707-7717
3. Shen, C. K. J., Tsai, K. J., Yang, C. H., Lee, P. C., Wang, W. T., and Chiu, M. J. (2009) Asymmetric expression patterns of brain transthyretin in normal mice and a transgenic mouse model of Alzheimer's disease Neuroscience 159, 638-646
4. Wu, Z. L., Ciallella, J. R., Flood, D. G., O'Kane, T. M., Bozyczko-Coyne, D., and Savage, M. J. (2006) Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease Neurobiol. Aging 27, 377-386
5. Li, X. Y., Masliah, E., Reixach, N., and Buxbaum, J. N. (2011) Neuronal Production of Transthyretin in Human and Murine Alzheimer's Disease: Is It Protective? J. Neurosci. 31, 12483-12490
6. Liu, L., Hou, J., Du, J. L., Chumanov, R. S., Xu, Q. G., Ge, Y., Johnson, J. A., and Murphy, R. M. (2009) Differential modification of Cys10 alters transthyretin's effect on β-amyloid aggregation and toxicity Protein Eng., Des. Sel. 22, 479-488
7. Giunta, S., Valli, M. B., Galeazzi, R., Fattoretti, P., Corder, E. H., and Galeazzi, L. (2005) Transthyretin inhibition of amylold β aggregation and toxicity Clin. Biochem. 38, 1112-1119
8. Costa, R., Ferreira-da-Silva, F., Saraiva, M. J., and Cardoso, I. (2008) Transthyretin protects against A-β peptide toxicity by proteolytic cleavage of the peptide: A mechanism sensitive to the Kunitz Protease Inhibitor PLoS One 3 e2899
9. Buxbaum, J. N., Ye, Z., Reixach, N., Friske, L., Levy, C., Das, P., Golde, T., Masliah, E., Roberts, A. R., and Bartfai, T. (2008) Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity Proc. Natl. Acad. Sci. U.S.A. 105, 2681-2686
10. Potter, H., Costa, D. A., Craechiolo, J. R., Bachstetter, A. D., Hughes, T. F., Bales, K. R., Paul, S. M., Mervis, R. F., and Arendash, G. W. (2007) Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms Neurobiol. Aging 28, 831-844
11. Hamilton, J. A. and Benson, M. D. (2001) Transthyretin: A review from a structural perspective Cell. Mol. Life Sci. 58, 1491-1521
12. Richardson, S. J. (2007) Cell and molecular biology of transthyretin and thyroid hormones Int. Rev. Cytol. 258, 137-193
13. Du, J. L., Cho, P. Y., Yang, D. T., and Murphy, R. M. (2012) Identification of β-amyloid-binding sites on transthyretin Protein Eng., Des. Sel. 25, 337-345
14. Du, J. L. and Murphy, R. M. (2010) Characterization of the interaction of β-amyloid with transthyretin monomers and tetramers Biochemistry 49, 8276-8289
15. Schwarzman, A. L., Gregori, L., Vitek, M. P., Lyubski, S., Strittmatter, W. J., Enghilde, J. J., Bhasin, R., Silverman, J., Weisgraber, K. H., Coyle, P. K., Zagorski, M. G., Talafous, J., Eisenberg, M., Saunders, A. M., Roses, A. D., and Goldgaber, D. (1994) Transthyretin sequesters amyloid-β protein and prevents amyloid formation Proc. Natl. Acad. Sci. U.S.A. 91, 8368-8372
16. Jiang, X., Smith, C. S., Petrassi, H. M., Hammarstrom, P., White, J. T., Sacchettini, J. C., and Kelly, J. W. (2001) An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured Biochemistry 40, 11442-11452
17. Pallitto, M. M. and Murphy, R. M. (2001) A mathematical model of the kinetics of β-amyloid fibril growth from the denatured state Biophys. J. 81, 1805-1822
18. Fancy, D. A. and Kodadek, T. (1999) Chemistry for the analysis of protein-protein interactions: Rapid and efficient cross-linking triggered by long wavelength light Proc. Natl. Acad. Sci. U.S.A. 96, 6020-6024
19. Xia, K., Zhang, S. J., Bathrick, B., Liu, S. Q., Garcia, Y., and Colon, W. (2012) Quantifying the kinetic stability of hyperstable proteins via time-dependent SDS trapping Biochemistry 51, 100-107
20. Murphy, R. M., Liu, L., Hou, J., Du, J. L., Chumanov, R. S., Xu, Q. G., Ge, Y., and Johnson, J. A. (2009) Differential modification of Cys10 alters transthyretin's effect on β-amyloid aggregation and toxicity Protein Eng., Des. Sel. 22, 479-488
21. Costa, R., Goncalves, A., Saralva, M. J., and Cardoso, I. (2008) Transthyretin binding to A-β peptide: Impact on A-β fibrillogenesis and toxicity FEBS Lett. 582, 936-942
22. Glabe, C. G. (2008) Structural classification of toxic amyloid oligomers J. Biol. Chem. 283, 29639-29643
23. Filipe, V., Hawe, A., and Jiskoot, W. (2010) Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates Pharm. Res. 27, 796-810
24. Glabe, C. G., Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., Rasool, S., Gurlo, T., and Butler, P. (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers Mol. Neurodegener. 2, 18
25. Sarsoza, F., Saing, T., Kayed, R., Dahlin, R., Dick, M., Broadwater-Hollifield, C., Mobley, S., Lott, I., Doran, E., Gillen, D., Anderson-Bergman, C., Cribbs, D. H., Glabe, C., and Head, E. (2009) A fibril-specific, conformation-dependent antibody recognizes a subset of Aβ plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain Acta Neuropathol. 118, 505-517
26. Glabe, C. G., Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., and Cotman, C. W. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300, 486-489
27. Keetch, C. A., Bromley, E. H. C., McCammon, M. G., Wang, N., Christodoulou, J., and Robinson, C. V. (2005) L55P transthyretin accelerates subunit exchange and leads to rapid formation of hybrid tetramers J. Biol. Chem. 280, 41667-41674
28. Brouillette, J., Caillierez, R., Zommer, N., Alves-Pires, C., Benilova, I., Blum, D., De Strooper, B., and Buee, L. (2012) Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid-β(1-42) Oligomers Are Revealed In Vivo by Using a Novel Animal Model J. Neurosci. 32, 7852-7861
29. Hammarstrom, P., Sekijima, Y., White, J. T., Wiseman, R. L., Lim, A., Costello, C. E., Altland, K., Garzuly, F., Budka, H., and Kelly, J. W. (2003) D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: A prescription for central nervous system amyloidosis? Biochemistry 42, 6656-6663
30. McCutchen, S. L., Colon, W., and Kelly, J. W. (1993) Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity Biochemistry 32, 12119-12127
31. Babbes, A. R. H., Powers, E. T., and Kelly, J. W. (2008) Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: The relationship between stability and amyloidosis Biochemistry 47, 6969-6984
32. Palaninathan, S. K., Mohamedmohaideen, N. N., Snee, W. C., Kelly, J. W., and Sacchettini, J. C. (2008) Structural Insight into pH-induced Conformational Changes within the Native Human Transthyretin Tetramer J. Mol. Biol. 382, 1157-1167
33. Ghanta, J., Shen, C. L., Kiessling, L. L., and Murphy, R. M. (1996) A strategy for designing inhibitors of β-amyloid toxicity J. Biol. Chem. 271, 29525-29528
34. Findeis, M. A., Musso, G. M., Arico-Muendel, C. C., Benjamin, H. W., Hundal, A. M., Lee, J. J., Chin, J., Kelley, M., Wakefield, J., Hayward, N. J., and Molineaux, S. M. (1999) Modified-peptide inhibitors of amyloid β-peptide polymerization Biochemistry 38, 6791-6800
35. Tjernberg, L. O., Naslund, J., Lindqvist, F., Johansson, J., Karlstrom, A. R., Thyberg, J., Terenius, L., and Nordstedt, C. (1996) Arrest of β-amyloid fibril formation by a pentapeptide ligand J. Biol. Chem. 271, 8545-8548
36. Gordon, D. J., Sciarretta, K. L., and Meredith, S. C. (2001) Inhibition of β-amyloid(40) fibrillogenesis and disassembly of β-amyloid(40) fibrils by short β-amyloid congeners containing N-methyl amino acids at alternate residues Biochemistry 40, 8237-8245
37. Rangachari, V., Davey, Z. S., Healy, B., Moore, B. D., Sonoda, L. K., Cusack, B., Maharvi, G. M., Fauq, A. H., and Rosenberry, T. L. (2009) Rationally designed dehydroalanine (ΔAla)-containing peptides inhibit amyloid-β (Aβ) peptide aggregation Biopolymers 91, 456-465
38. Lowe, T. L., Strzelec, A., Kiessling, L. L., and Murphy, R. M. (2001) Structure-function relationships for inhibitors of β-amyloid toxicity containing the recognition sequence KLVFF Biochemistry 40, 7882-7889
39. Kim, J. R., Gibson, T. J., and Murphy, R. M. (2003) Targeted control of kinetics of β-amyloid self-association by surface tension-modifying peptides J. Biol. Chem. 278, 40730-40735
40. Kim, J. R. and Murphy, R. M. (2004) Mechanism of accelerated assembly of β-amyloid filaments into fibrils by KLVFFK6 Biophys. J. 86, 3194-3203
41. Li, H. M., Wang, B. P., Wang, Z. L., Guo, Q. X., Tabuchi, K., Hammer, R. E., Sudhof, T. C., and Zheng, H. (2010) Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP Proc. Natl. Acad. Sci. U.S.A. 107, 17362-17367
42. Velayudhan, L., Killick, R., Hye, A., Kinsey, A., Guentert, A., Lynham, S., Ward, M., Leung, R., Lourdusamy, A., To, A. W. M., Powell, J., and Lovestone, S. (2012) Plasma transthyretin as a candidate marker for Alzheimer's disease J. Alzheimer's Dis. 28, 369-375